文献速递白血病MDS 与骨髓增殖性肿瘤

黏连蛋白突变对唐氏综合征髓系白血病HLA-II类表达的影响

The effect of cohesin mutations on HLA-class II expression in the myeloid leukemia of Down syndrome.
PubMed 文献 · Leukemia · 2026-07-21

研究利用RAD21突变CMY细胞系、RAD21校正的同源克隆及患者数据,探究黏连蛋白突变在白血病进展中的作用。RNA测序显示黏连蛋白突变显著下调HLA-II类基因,ML-DS中HLA-DR低于TAM且降低与白血病进展风险增加相关。多组学分析揭示RAD21单倍剂量不足改变染色质可及性并损害GATA1s和CIITA占据,校正RAD21可增加CIITA染色质结合。

要点

  • 黏连蛋白突变下调HLA-II类基因表达。
  • ML-DS中HLA-DR低于TAM,降低与进展风险增加相关。
  • RAD21单倍剂量不足损害GATA1s和CIITA染色质占据。

核心结论

  • 黏连蛋白可能通过改变HLA-II类基因表达促进白血病。

研究设计与样本

  • 使用RAD21突变CMY细胞系和RAD21校正的CMY同源克隆,并结合患者数据进行研究。

主要发现

  • RNA测序显示黏连蛋白突变时HLA-II类基因显著下调。
  • ML-DS中HLA-DR低于TAM,且降低水平与白血病进展风险增加相关。
  • 多组学分析显示RAD21单倍剂量不足改变染色质可及性并损害GATA1s和CIITA占据。
  • 校正RAD21后CIITA染色质结合增加。
  • 其他AML亚型中RAD21或STAG2表达降低也显示HLA-II类基因表达减少。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Children with Down syndrome (DS) frequently develop transient abnormal myelopoiesis that can evolve to the myeloid leukemia of DS (ML-DS). TAM spontaneously resolves in most cases but progresses to ML-DS with additional mutations, most commonly in the cohesin complex. However, the mechanisms by which these alterations promote leukemia are unknown. We leveraged the RAD21-mutant CMY cell line and RAD21-corrected CMY isogenic clones, as well as patient data, to investigate the effect of cohesin mutations during leukemia progression. RNA-sequencing revealed that HLA-class II genes were significantly down-regulated with cohesin mutations. Furthermore, HLA-DR was found to be lower in ML-DS relative to TAM, and these decreased levels were associated with increased risk of leukemia progression. Multi-omic analyses revealed that haploinsufficiency of RAD21 altered chromatin accessibility and impaired the occupancy of GATA1s and CIITA, the master regulator of HLA-class II gene expression. Chromatin binding of CIITA was increased with RAD21 correction, providing a mechanism by which restoration of cohesin improves HLA-class II expression. Finally, decreased levels of RAD21 or STAG2 expression in other subtypes of AML also exhibited reduced expression of HLA-class II genes. Thus, cohesin may contribute to leukemia by altering HLA-class II gene expression.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Boucher AC, Rosikiewicz W, Cotton A, et al. The effect of cohesin mutations on HLA-class II expression in the myeloid leukemia of Down syndrome. Leukemia. 2026. PMID: 42481796. doi:10.1038/s41375-026-03074-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。